Vascular Stents Market Overview
The global Vascular Stents Market is experiencing steady growth driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive vascular procedures, technological advancements in stent design and materials, and growing healthcare expenditure. The development of drug-eluting, biodegradable, and advanced polymer-based stents is also supporting innovation and expanding treatment options.
According to the Market Research Future report updated August 24, 2026, the global Vascular Stents Market was valued at USD 6.921 billion in 2024 and is projected to grow from USD 7.171 billion in 2025 to USD 10.22 billion by 2035, registering a CAGR of 3.61% during the forecast period of 2025–2035. North America accounted for 44.79% of the market in 2024, making it the leading regional market, while Asia-Pacific is emerging as the fastest-growing region. Drug-Eluting Stents represent the dominant type, Coronary Artery Disease is the largest application, Metal Stents lead by material, and Hospitals remain the dominant end-use segment.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Vascular Stents Market include:
Medtronic
Boston Scientific
Abbott Laboratories
B. Braun Melsungen AG
Terumo Corporation
Cordis Corporation
Cook Medical
Johnson & Johnson
Stryker Corporation
The Vascular Stents Market is being shaped by technological advancements in drug-eluting stents, bioresorbable materials, advanced coatings, and improved stent designs. Manufacturers are focusing on enhancing efficacy and safety while reducing complications associated with conventional stents. Regulatory approvals and reimbursement policies are also influencing the pace of innovation and adoption across healthcare systems.
The Vascular Stents Market can be segmented by Type, Application, Material, End Use, and Region. By type, the market includes Drug-Eluting Stents, Bare-Metal Stents, and Biodegradable Stents. Applications include Coronary Artery Disease, Peripheral Vascular Disease, and Carotid Artery Disease. By material, the market comprises Metal Stents, Polymer Stents, and Composite Stents, while end users include Hospitals, Cardiac Catheterization Labs, and Ambulatory Surgical Centers.
The market presents significant opportunities through the development of bioresorbable stents, advanced polymer materials, expansion into emerging markets, and integration of digital health technologies. Increasing healthcare investments across developing regions and the growing need for minimally invasive cardiovascular interventions are expected to create additional opportunities for manufacturers.
Recent Developments and Market Trends:
Drug-Eluting Stents continue to dominate the market because their medication-releasing technology helps reduce the risk of restenosis and supports improved post-procedure outcomes.
Bioresorbable and biodegradable stent technologies are gaining attention as manufacturers seek solutions that can minimize long-term complications and support improved vessel healing.
Polymer-based stents are emerging as an important growth opportunity because advances in material science are improving biocompatibility and supporting the development of bioresorbable solutions.
Minimally invasive vascular interventions continue to drive demand as healthcare providers and patients increasingly favor procedures associated with shorter recovery periods.
Asia-Pacific is emerging as a high-potential market as healthcare investments, cardiovascular disease prevalence, urbanization, and access to advanced vascular treatments increase.
Reasons to Buy the Report:
Understand the current market size, growth trajectory, and forecast outlook for the global Vascular Stents Market through 2035.
Analyze the leading type, application, material, end-use, and regional segments shaping market demand.
Evaluate emerging opportunities in drug-eluting, biodegradable, polymer-based, and next-generation vascular stent technologies.
Identify technological and regulatory developments influencing vascular stent innovation and adoption.
Assess competitive dynamics, strategic developments, and regional opportunities among leading Vascular Stents Market participants.
Future Outlook:
The Vascular Stents Market is expected to maintain steady growth through 2035 as cardiovascular disease prevalence, minimally invasive procedures, technological innovation, and healthcare expenditure continue to support demand. Drug-Eluting Stents will remain the dominant type, while Bare-Metal Stents are identified as an emerging and rapidly developing category. Coronary Artery Disease will continue to represent the largest application, supported by the substantial need for coronary interventions, while Peripheral Vascular Disease is emerging as a faster-growing application. Metal Stents will retain their dominant position because of their durability and established clinical acceptance, whereas Polymer Stents are gaining traction due to their biocompatibility and bioresorbable potential. Hospitals will remain the leading end-use setting, while Cardiac Catheterization Labs and Ambulatory Surgical Centers continue to support minimally invasive procedures. North America will retain its leadership with a 44.79% market share in 2024, while Asia-Pacific is expected to remain the fastest-growing regional market. Overall, the global Vascular Stents Market is projected to increase from USD 6.921 billion in 2024 to USD 10.22 billion by 2035 at a CAGR of 3.61%.
➤➤Explore Our Latest Related Reports:
